MADRIGAL PHARMACEUTICALS, INC. (MDGL) Total assets 2017–2025
MADRIGAL PHARMACEUTICALS, INC. (MDGL) total assets at each fiscal year-end, per SEC filings.
$1.3BFY2025 · since FY2017: $192.3M → $1.3B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.3B | +20.9% |
| FY2024 | $1.0B | +62.7% |
| FY2023 | $640.5M | +76.7% |
| FY2022 | $362.6M | +32.6% |
| FY2021 | $273.3M | -4.8% |
| FY2020 | $287.0M | -35.1% |
| FY2019 | $442.1M | -8.9% |
| FY2018 | $485.4M | +152.4% |
| FY2017 | $192.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MDGL financial trends
MDGL RevenueMDGL Net incomeMDGL Net marginMDGL Gross profitMDGL Gross marginMDGL Operating incomeMDGL Operating marginMDGL Operating cash flowMDGL Free cash flowMDGL Capital expendituresMDGL Return on equityMDGL Stock buybacksMDGL Dividends paidMDGL Total liabilitiesMDGL Shareholders’ equityMDGL overview →